Phase II clinical trial of amatuximab, a chimeric anti-mesothelin antibody with pemetrexed and cisplatin in advanced unresectable pleural mesothelioma

Por Hassan, Raffit, Kindler, Hedy L., Jahan, Thierry, Bazhenova, Lyudmila, Reck, Martin, Thomas, Anish, Pastan, Ira, Parno, Jeff, O’Shannessy, Daniel J., Fatato, Penny, Maltzman, Julia D., Wallin, Bruce A.
Publicado no Clin Cancer Res (2014)

Significance of Folate Receptor alpha and Thymidylate Synthase Protein Expression in Patients with Non-Small Cell Lung Cancer treated with Pemetrexed

Por Christoph, Daniel C, Asuncion, Bernadette Reyna, Hassan, Biftu, Tran, Cindy, Maltzman, Julia D, O’Shannessy, Daniel J, Wynes, Murry W, Gauler, Thomas C, Wohlschlaeger, Jeremias, Hoiczyk, Mathias, Schuler, Martin, Eberhardt, Wilfried E, Hirsch, Fred R
Publicado em 2013

Folate Receptor-α (FOLR1) Expression and Function in Triple Negative Tumors

Por Necela, Brian M., Crozier, Jennifer A., Andorfer, Cathy A., Lewis-Tuffin, Laura, Kachergus, Jennifer M., Geiger, Xochiquetzal J., Kalari, Krishna R., Serie, Daniel J., Sun, Zhifu, Aspita, Alvaro Moreno, O’Shannessy, Daniel J., Maltzman, Julia D., McCullough, Ann E., Pockaj, Barbara A., Cunliffe, Heather E., Ballman, Karla V., Thompson, E. Aubrey, Perez, Edith A.
Publicado no PLoS One (2015)

Correction: Folate Receptor-α (FOLR1) Expression and Function in Triple Negative Tumors

Por Necela, Brian M., Crozier, Jennifer A., Andorfer, Cathy A., Lewis-Tuffin, Laura, Kachergus, Jennifer M., Geiger, Xochiquetzal J., Kalari, Krishna R., Serie, Daniel J., Sun, Zhifu, Moreno-Aspitia, Alvaro, O’Shannessy, Daniel J., Maltzman, Julia D., McCullough, Ann E., Pockaj, Barbara A., Cunliffe, Heather E., Ballman, Karla V., Thompson, E. Aubrey, Perez, Edith A.
Publicado no PLoS One (2015)